Related Experiment Video

Updated: Jun 16, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new

Vasilios G Athyros1, Konstantinos Tziomalos, Matilda Florentin

  • 1Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece.

Current Medical Research and Opinion
|February 6, 2010
PubMed

Insights

High-dose statin therapy before percutaneous coronary intervention (PCI) may reduce major adverse cardiac events and myocardial necrosis. This benefit might be specific to patients undergoing PCI, with distinct mechanisms for target and non-target vessels.

Area of Science:

  • Cardiology
  • Pharmacology
  • Interventional Cardiology

Background:

  • Intensive statin treatment is beneficial for acute coronary syndromes.
  • The specific benefit of statins in patients undergoing percutaneous coronary intervention (PCI) requires further investigation.
  • Statin loading strategies may impact clinical outcomes post-PCI.

Purpose of the Study:

  • To discuss the results of statin loading trials in the context of PCI.
  • To explore the potential mechanisms behind statin's protective effects on target and non-target vessels.
  • To evaluate the impact of high-dose statin loading on major adverse cardiac events and myocardial necrosis.

Main Methods:

  • Review and discussion of existing literature on statin loading trials.
  • Analysis of clinical outcomes, including major adverse cardiac events, revascularization rates, and myocardial necrosis.
  • Exploration of proposed pharmacological mechanisms of statins in the context of PCI.

Main Results:

  • High-dose statin loading before PCI may decrease major adverse cardiac events.
  • Statin therapy appears to reduce myocardial necrosis and revascularization of both target and non-target vessels post-PCI.
  • Distinct mechanisms may underlie statin's protective effects on different vascular territories.

Conclusions:

  • Statin loading prior to PCI shows promise in improving patient outcomes.
  • Further research is warranted to elucidate the specific mechanisms of action.
  • The findings support the consideration of high-dose statin therapy in patients undergoing PCI.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...